1. Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase
   Yan Zhang et al, 2016, Oncotarget CrossRef
2. Programmed cell death in stem cell-based therapy: Mechanisms and clinical applications
   Xi-Min Hu et al, 2021, World Journal of Stem Cells CrossRef
3. Therapeutic effect of N, N‐Diphenyl‐1,4‐phenylenediamine and adipose‐derived stem cells coadministration on diabetic cardiomyopathy in type 1 diabetes mellitus‐rat model
   Hany M. Abd El‐lateef et al, 2024, Journal of Experimental Zoology Part A: Ecological and Integrative Physiology CrossRef
4. Transplantation of bone marrow-derived endothelial progenitor cells attenuates cerebral ischemia and reperfusion injury by inhibiting neuronal apoptosis, oxidative stress and nuclear factor-κB expression
   JING QIU et al, 2013, International Journal of Molecular Medicine CrossRef
5. miR-145 modulates lncRNA-ROR and Sox2 expression to maintain human amniotic epithelial stem cell pluripotency and β islet-like cell differentiation efficiency
   Gang Zou et al, 2016, Gene CrossRef
6. Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy
   Masashi Kawamura et al, 2017, Cardiovascular Diabetology CrossRef
7. Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria
   Mandip Joshi et al, 2014, Molecular and Cellular Biochemistry CrossRef
8. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell
   Shahzad Khan et al, 2021, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
9. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy
   Muhammad Ali et al, 2015, Molecular and Cellular Biochemistry CrossRef
10. Pinocembrin ex vivo preconditioning improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline-induced pulmonary hypertension in rats
    Lamiaa A. Ahmed et al, 2017, Biochemical Pharmacology CrossRef
11. Decreased Circulating Endothelial Progenitor Cell Levels in Patients with Heart Failure with Preserved Ejection Fraction
    Chia-Hung Chiang et al, 2013, Cardiology CrossRef
12. Stem cells-derived exosomes as cardiac regenerative agents
    Raheleh Farahzadi et al, 2024, IJC Heart & Vasculature CrossRef
13. Regenerative Medicine Strategies for Hypoplastic Left Heart Syndrome
    Josue Chery et al, 2016, Tissue Engineering Part B: Reviews CrossRef
14. Current advances in the study of diabetic cardiomyopathy: From clinicopathological features to molecular therapeutics (Review)
    Lin Sun et al, 2019, Molecular Medicine Reports CrossRef
15. Transfusion of CXCR4-Primed Endothelial Progenitor Cells Reduces Cerebral Ischemic Damage and Promotes Repair in db/db Diabetic Mice
    Ji Chen et al, 2012, PLoS ONE CrossRef
16. Stem cells and diabetic cardiomyopathy: from pathology to therapy
    Mingfei Liu et al, 2016, Heart Failure Reviews CrossRef
17. Stem cell therapy for the systemic right ventricle
    Ming-Sing Si et al, 2017, Expert Review of Cardiovascular Therapy CrossRef
18. Mouse Bone Marrow-Derived Endothelial Progenitor Cells Do Not Restore Radiation-Induced Microvascular Damage
    Ingar Seemann et al, 2014, ISRN Cardiology CrossRef
19. Green tea epigallocatechin gallate enhances cardiac function restoration through survival signaling expression in diabetes mellitus rats with autologous adipose tissue-derived stem cells
    Tung-Sheng Chen et al, 2017, Journal of Applied Physiology CrossRef
20. Regulation of Endothelial Progenitor Cell Functions in Ischemic Heart Disease: New Therapeutic Targets for Cardiac Remodeling and Repair
    Huai Huang et al, 2022, Frontiers in Cardiovascular Medicine CrossRef